Human cytomegalovirus induction of a unique signalsome during viral entry into monocytes mediates distinct functional changes: A strategy for viral dissemination

Journal of Leukocyte Biology

Volumn 92, Issue 4, 2012, Pages 743-752

  Chan, Gary ^a,c   Nogalski, Maciej T ^a   Stevenson, Emily V ^a   Yurochko, Andrew D ^a,b  

^a Center for Molecular and Tumor Virology   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

EGFR; Inflammation; Integrin; Signaling; Transcriptome

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; CELL RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; INTEGRIN;

CELL ACTIVATION; CELL MOTILITY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; HUMAN; MACROPHAGE; MOLECULAR MECHANICS; MONOCYTE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VIRUS ENTRY;

CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; INTEGRINS; MONOCYTES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, VIRUS; SIGNAL TRANSDUCTION; VIRUS INTERNALIZATION;

HUMAN HERPESVIRUS 5;

EID: 84868145067     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0112040     Document Type: Review

References (80)

1. Mocarski, E. S., Courcell, C. T. (2001) Cytomegalovirus and their replication. In Fields Virology, Vol. 2 (Knipe, D. M. Howley, eds.), P. M. Lippincott, Williams and Wilkins, Philadelphia, PA, USA, 2629-2673.
2. Britt, W. (2008) Manifestations of human cytomegalovirus infection: proposed mechanisms of acute and chronic disease. In Current Topics in Microbiology and Immunology: Human Cytomegalovirus, Vol. 325 (Shenk, T. Stinski, eds.), M. Springer-Verlag, Berlin and Heidelberg, Germany, 417-470.
3. Reeves, M. B., Sinclair, J. H. (2010) Analysis of latent viral gene expression in natural and experimental latency models of human cytomegalovirus and its correlation with histone modifications at a latent promoter. J. Gen. Virol. 91, 599-604.
4. Goodrum, F., Caviness, K., Zagallo, P. (2012) Human cytomegalovirus persistence. Cell. Microbiol. 14, 644-655.
5. Soderberg-Naucler, C. (2008) HCMV microinfections in inflammatory diseases and cancer. J. Clin. Virol. 41, 218-223.
6. Crough, T., Khanna, R. (2009) Immunobiology of human cytomegalovirus: from bench to bedside. Clin. Microbiol. Rev. 22, 76-98.
7. Sinclair, J., Sissons, P. (1996) Latent and persistent infections of monocytes and macrophages. Intervirology 39, 293-301.
8. Sinzger, C., Jahn, G. (1996) Human cytomegalovirus cell tropism and pathogenesis. Intervirology 39, 302-319.
9. Booss, J., Dann, P. R., Griffith, B. P., Kim, J. H. (1989) Host defense response to cytomegalovirus in the central nervous system. Predominance of the monocyte. Am. J. Pathol. 134, 71-78.
10. Smith, M. S., Bentz, G. L., Alexander, J. S., Yurochko, A. D. (2004) Human cytomegalovirus induces monocyte differentiation and migration as a strategy for dissemination and persistence. J. Virol. 78, 4444-4453.
11. Taylor-Wiedeman, J., Sissons, J. G., Borysiewicz, L. K., Sinclair, J. H. (1991) Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J. Gen. Virol. 72, 2059-2064.
12. Gerna, G., Baldanti, F., Revello, M. G. (2004) Pathogenesis of human cytomegalovirus infection and cellular targets. Hum. Immunol. 65, 381-386.
13. Weber, B., Doerr, H. W. (1994) Diagnosis and epidemiology of transfusion-associated human cytomegalovirus infection: recent developments. Infusionsther. Transfusionsmed. 21 (Suppl. 1), 32-39.
14. Fish, K. N., Depto, A. S., Moses, A. V., Britt, W., Nelson, J. A. (1995) Growth kinetics of human cytomegalovirus are altered in monocyte-derived macrophages. J. Virol. 69, 3737-3743.
15. Ibanez, C. E., Schrier, R., Ghazal, P., Wiley, C., Nelson, J. A. (1991) Human cytomegalovirus productively infects primary differentiated macrophages. J. Virol. 65, 6581-6588.
16. Whitelaw, D. M. (1972) Observations on human monocyte kinetics after pulse labeling. Cell Tissue Kinet. 5, 311-317.
17. Chan, G., Bivins-Smith, E. R., Smith, M. S., Smith, P. M., Yurochko, A. D. (2008) Transcriptome analysis reveals human cytomegalovirus reprograms monocyte differentiation toward an M1 macrophage. J. Immunol. 181, 698-711.
18. Yurochko, A. D., Huang, E. S. (1999) Human cytomegalovirus binding to human monocytes induces immunoregulatory gene expression. J. Immunol. 162, 4806-4816.
19. Chan, G., Nogalski, M. T., Yurochko, A. D. (2009) Activation of EGFR on monocytes is required for human cytomegalovirus entry and mediates cellular motility. Proc. Natl. Acad. Sci. USA 106, 22369-22374.
20. Smith, M. S., Bentz, G. L., Smith, P. M., Bivins, E. R., Yurochko, A. D. (2004) HCMV activates PI(3)K in monocytes and promotes monocyte motility and transendothelial migration in a PI(3)K-dependent manner. J. Leukoc. Biol. 76, 65-76.
21. Mocarski E. S., Jr., (2002) Virus self-improvement through inflammation: no pain, no gain. Proc. Natl. Acad. Sci. USA 99, 3362-3364.
22. Saederup, N., Aguirre, S. A., Sparer, T. E., Bouley, D. M., Mocarski, E. S. (2001) Murine cytomegalovirus CC chemokine homolog MCK-2 (m131-129) is a determinant of dissemination that increases inflammation at initial sites of infection. J. Virol. 75, 9966-9976.
23. Chan, G., Bivins-Smith, E. R., Smith, M. S., Yurochko, A. D. (2009) NF-κB and phosphatidylinositol 3-kinase activity mediates the HCMVinduced atypical M1/M2 polarization of monocytes. Virus Res. 144, 329-333.
24. Soderberg-Naucler, C., Streblow, D. N., Fish, K. N., Allan-Yorke, J., Smith, P. P., Nelson, J. A. (2001) Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependent. J. Virol. 75, 7543-7554.
25. Sinzger, C., Plachter, B., Grefte, A., The, T. H., Jahn, G. (1996) Tissue macrophages are infected by human cytomegalovirus in vivo. J. Infect. Dis. 173, 240-245.
26. Noyola, D. E., Demmler, G. J., Williamson, W. D., Griesser, C., Sellers, S., Llorente, A., Littman, T., Williams, S., Jarrett, L., Yow, M. D. (2000) Cytomegalovirus urinary excretion and long term outcome in children with congenital cytomegalovirus infection. Congenital CMV Longitudinal Study Group. Ped. Infect. Dis. J. 19, 505-510.
27. Kondo, K., Kaneshima, H., Mocarski, E. S. (1994) Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc. Natl. Acad. Sci. USA 91, 11879-11883.
28. Maciejewski, J. P., Bruening, E. E., Donahue, R. E., Mocarski, E. S., Young, N. S., St Jeor, S. C. (1992) Infection of hematopoietic progenitor cells by human cytomegalovirus. Blood 80, 170-178.
29. Smith, M. S., Bivins-Smith, E. R., Tilley, A. M., Bentz, G. L., Chan, G., Minard, J., Yurochko, A. D. (2007) Roles of phosphatidylinositol 3-kinase and NF-κB in human cytomegalovirus-mediated monocyte diapedesis and adhesion: strategy for viral persistence. J. Virol. 81, 7683-7694.
30. Yurochko, A. D., Hwang, E. S., Rasmussen, L., Keay, S., Pereira, L., Huang, E. S. (1997) The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-κB during infection. J. Virol. 71, 5051-5059.
31. Yurochko, A. D., Kowalik, T. F., Huong, S. M., Huang, E. S. (1995) Human cytomegalovirus upregulates NF-κB activity by transactivating the NF-κB p105/p50 and p65 promoters. J. Virol. 69, 5391-5400.
32. Yurochko, A. D., Mayo, M. W., Poma, E. E., Baldwin A. S., Jr., Huang, E. S. (1997) Induction of the transcription factor Sp1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/ p50 NF-κB promoters. J. Virol. 71, 4638-4648.
33. Chan, G., Nogalski, M. T., Bentz, G. L., Smith, M. S., Parmater, A., Yurochko, A. D. (2010) PI(3)K-dependent upregulation of Mcl-1 by human cytomegalovirus is mediated by epidermal growth factor receptor and inhibits apoptosis in short-lived monocytes. J. Immunol. 184, 3213-3222.
34. Mocarski, E. S., Shenk, T., Pass, R. F. (2007) Cytomegaloviruses. In Fields Virology, Vol. 2 (Knipe, D. M. Howley, eds.), P. M. Lippincott, Williams and Wilkins, Philadelphia, PA, USA, 2701-2772.
35. Grundy, J. E., McKeating, J. A., Griffiths, P. D. (1987) Cytomegalovirus strain AD169 binds β 2 microglobulin in vitro after release from cells. J. Gen. Virol. 68, 777-784.
36. Wright, J. F., Kurosky, A., Wasi, S. (1994) An endothelial cell-surface form of annexin II binds human cytomegalovirus. Biochem. Biophys. Res. Commun. 198, 983-989.
37. Soderberg, C., Giugni, T. D., Zaia, J. A., Larsson, S., Wahlberg, J. M., Moller, E. (1993) CD13 (human aminopeptidase N) mediates human cytomegalovirus infection. J. Virol. 67, 6576-6585.
38. Boehme, K. W., Guerrero, M., Compton, T. (2006) Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells. J. Immunol. 177, 7094-7102.
39. Compton, T., Nowlin, D. M., Cooper, N. R. (1993) Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate. Virology 193, 834-841.
40. Kari, B., Gehrz, R. (1992) A human cytomegalovirus glycoprotein complex designated gC-II is a major heparin-binding component of the envelope. J. Virol. 66, 1761-1764.
41. Soroceanu, L., Akhavan, A., Cobbs, C. S. (2008) Platelet-derived growth factor-α receptor activation is required for human cytomegalovirus infection. Nature 455, 391-395.
42. Wang, X., Huong, S. M., Chiu, M. L., Raab-Traub, N., Huang, E. S. (2003) Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus. Nature 424, 456-461.
43. Feire, A. L., Koss, H., Compton, T. (2004) Cellular integrins function as entry receptors for human cytomegalovirus via a highly conserved disintegrin-like domain. Proc. Natl. Acad. Sci. USA 101, 15470-15475.
44. Dreyfuss, J. L., Regatieri, C. V., Jarrouge, T. R., Cavalheiro, R. P., Sampaio, L. O., Nader, H. B. (2009) Heparan sulfate proteoglycans: structure, protein interactions and cell signaling. An. Acad. Bras. Cienc. 81, 409-429.
45. Wang, X., Huang, D. Y., Huong, S. M., Huang, E. S. (2005) Integrin αβ3 is a coreceptor for human cytomegalovirus. Nat. Med. 11, 515-521.
46. Juckem, L. K., Boehme, K. W., Feire, A. L., Compton, T. (2008) Differential initiation of innate immune responses induced by human cytomegalovirus entry into fibroblast cells. J. Immunol. 180, 4965-4977.
47. Inaba, T., Shimano, H., Gotoda, T., Harada, K., Shimada, M., Ohsuga, J., Watanabe, Y., Kawamura, M., Yazaki, Y., Yamada, N. (1993) Expression of platelet-derived growth factor β receptor on human monocytederived macrophages and effects of platelet-derived growth factor BB dimer on the cellular function. J. Biol. Chem. 268, 24353-24360.
48. Hynes, R. O. (2002) Integrins: bidirectional, allosteric signaling machines. Cell 110, 673-687.
49. Albert, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., Walter, P. (2002) Molecular Biology of the Cell. Garland Science, New York, NY, USA.
50. Giancotti, F. G., Ruoslahti, E. (1999) Integrin signaling. Science 285, 1028-1032.
51. Schlaepfer, D. D., Hanks, S. K., Hunter, T., van der Geer, P. (1994) Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature 372, 786-791.
52. Wary, K. K., Mainiero, F., Isakoff, S. J., Marcantonio, E. E., Giancotti, F. G. (1996) The adaptor protein Shc couples a class of integrins to the control of cell cycle progression. Cell 87, 733-743.
53. Wary, K. K., Mariotti, A., Zurzolo, C., Giancotti, F. G. (1998) A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth. Cell 94, 625-634.
54. Yamada, K. M., Miyamoto, S. (1995) Integrin transmembrane signaling and cytoskeletal control. Curr. Opin. Cell Biol. 7, 681-689.
55. Bentz, G. L., Yurochko, A. D. (2008) Human CMV infection of endothelial cells induces an angiogenic response through viral binding to EGF receptor and β1 and β3 integrins. Proc. Natl. Acad. Sci. USA 105, 5531-5536.
56. Nogalski, M. T., Chan, G., Stevenson, E. V., Gray, S., Yurochko, A. D. (2011) Human cytomegalovirus-regulated paxillin in monocytes links cellular pathogenic motility to the process of viral entry. J. Virol. 85, 1360-1369.
57. Bodaghi, B., Slobbe-van Drunen, M. E., Topilko, A., Perret, E., Vossen, R. C., van Dam-Mieras, M. C., Zipeto, D., Virelizier, J. L., LeHoang, P., Bruggeman, C. A., Michelson, S. (1999) Entry of human cytomegalovirus into retinal pigment epithelial and endothelial cells by endocytosis. Invest. Ophthalmol. Vis. Sci. 40, 2598-2607.
58. Ryckman, B. J., Jarvis, M. A., Drummond, D. D., Nelson, J. A., Johnson, D. C. (2006) Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion. J. Virol. 80, 710-722.
59. Compton, T., Nepomuceno, R. R., Nowlin, D. M. (1992) Human cytomegalovirus penetrates host cells by pH-independent fusion at the cell surface. Virology 191, 387-395.
60. Straschewski, S., Patrone, M., Walther, P., Gallina, A., Mertens, T., Frascaroli, G. (2011) Protein pUL128 of human cytomegalovirus is necessary for monocyte infection and blocking of migration. J. Virol. 85, 5150-5158.
61. Maidji, E., Genbacev, O., Chang, H. T., Pereira, L. (2007) Developmental regulation of human cytomegalovirus receptors in cytotrophoblasts correlates with distinct replication sites in the placenta. J. Virol. 81, 4701-4712.
62. Felding-Habermann, B. (2003) Integrin adhesion receptors in tumor metastasis. Clin. Exp. Metastasis. 20, 203-213.
63. Holzmann, B., Gosslar, U., Bittner, M. (1998) β4 Integrins and tumor metastasis. Curr. Top. Microbiol. Immunol. 231, 125-141.
64. Brown, M. C., Turner, C. E. (2004) Paxillin: adapting to change. Physiol. Rev. 84, 1315-1339.
65. Stanton, R. J., McSharry, B. P., Rickards, C. R., Wang, E. C., Tomasec, P., Wilkinson, G. W. (2007) Cytomegalovirus destruction of focal adhesions revealed in a high-throughput Western blot analysis of cellular protein expression. J. Virol. 81, 7860-7872.
66. Real, F. X., Rettig, W. J., Chesa, P. G., Melamed, M. R., Old, L. J., Mendelsohn, J. (1986) Expression of epidermal growth factor receptor in human cultured cells and tissues: relationship to cell lineage and stage of differentiation. Cancer Res. 46, 4726-4731.
67. Sipka, S., Szanto, S., Szucs, K., Kovacs, I., Kiss, E., Antal-Szamas, P., Lakos, G., Aleksza, M., Illes, A., Gergely, P., Szegedi, G. (2001) Decreased arachidonic acid release in peripheral blood monocytes of patients with systemic lupus erythematosus. J. Rheumatol. 28, 2012-2017.
68. Lamb, D. J., Modjtahedi, H., Plant, N. J., Ferns, G. A. (2004) EGF mediates monocyte chemotaxis and macrophage proliferation and EGF receptor is expressed in atherosclerotic plaques. Atherosclerosis 176, 21-26.
69. Prada, P. O., Ropelle, E. R., Mourao, R. H., de Souza, C. T., Pauli, J. R., Cintra, D. E., Schenka, A., Rocco, S. A., Rittner, R., Franchini, K. G., Vassallo, J., Velloso, L. A., Carvalheira, J. B., Saad, M. J. (2009) EGFR tyrosine kinase inhibitor (PD153035) improves glucose tolerance and insulin action in high-fat diet-fed mice. Diabetes 58, 2910-2919.
70. Cheon, H., Woo, Y. S., Lee, J. Y., Kim, H. S., Kim, H. J., Cho, S., Won, N. H., Sohn, J. (2007) Signaling pathway for 2,3,7,8-tetrachlorodibenzop-dioxin-induced TNF-β production in differentiated THP-1 human macrophages. Exp. Mol. Med. 39, 524-534.
71. Eales-Reynolds, L. J., Laver, H., Modjtahedi, H. (2001) Evidence for the expression of the EGF receptor on human monocytic cells. Cytokine 16, 169-172.
72. Moon, D. O., Kim, M. O., Lee, J. D., Choi, Y. H., Lee, M. K., Kim, G. Y. (2007) Molecular mechanisms of ZD1839 (Iressa)-induced apoptosis in human leukemic U937 cells. Acta Pharmacol. Sin. 28, 1205-1214.
73. Valente, R. C., Nascimento, C. R., Araujo, E. G., Rumjanek, V. M. (2009) mCD14 expression in human monocytes is downregulated by ouabain via transactivation of epithelial growth factor receptor and activation of p38 mitogen-activated protein kinase. Neuroimmunomodulation 16, 228-236.
74. El Zein, N., D'Hondt, S., Sariban, E. (2010) Crosstalks between the receptors tyrosine kinase EGFR and TrkA and the GPCR, FPR, in human monocytes are essential for receptors-mediated cell activation. Cell. Signal. 22, 1437-1447.
75. LaMarca, H. L., Nelson, A. B., Scandurro, A. B., Whitley, G. S., Morris, C. A. (2006) Human cytomegalovirus-induced inhibition of cytotrophoblast invasion in a first trimester extravillous cytotrophoblast cell line. Placenta 27, 137-147.
76. Soderberg, C., Larsson, S., Bergstedt-Lindqvist, S., Moller, E. (1993) Identification of blood mononuclear cells permissive of cytomegalovirus infection in vitro. Transplant. Proc. 25, 1416-1418.
77. Isaacson, M. K., Feire, A. L., Compton, T. (2007) Epidermal growth factor receptor is not required for human cytomegalovirus entry or signaling. J. Virol. 81, 6241-6247.
78. Ryckman, B. J., Chase, M. C., Johnson, D. C. (2008) HCMV gH/gL/ UL128-131 interferes with virus entry into epithelial cells: evidence for cell type-specific receptors. Proc. Natl. Acad. Sci. USA 16, 14118-14123.
79. Edick, M. J., Tesfay, L., Lamb, L. E., Knudsen, B. S., Miranti, C. K. (2007) Inhibition of integrin-mediated crosstalk with epidermal growth factor receptor/Erk or Src signaling pathways in autophagic prostate epithelial cells induces caspase-independent death. Mol. Biol. Cell 18, 2481-2490.
80. Klingemann, H. G., Dedhar, S. (1989) Distribution of integrins on human peripheral blood mononuclear cells. Blood 74, 1348-1354.